Mural Oncology (MURA)
3.79
0.07 (1.88%)
At close: Jan 30, 2025, 12:01 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 |
| Net Income | -207.45M | -189.81M | -175.43M |
| Depreciation & Amortization | 2.57M | 1.54M | 1.47M |
| Stock-Based Compensation | 24.11M | 11.93M | 11.50M |
| Other Working Capital | -13.48M | 7.75M | 5.79M |
| Other Non-Cash Items | n/a | 15.01M | 14.45M |
| Deferred Income Tax | n/a | -15.01M | -14.45M |
| Change in Working Capital | -13.48M | 7.75M | 5.79M |
| Operating Cash Flow | -194.25M | -168.59M | -156.67M |
| Capital Expenditures | -3.45M | -5.51M | -4.38M |
| Acquisitions | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a |
| Investing Cash Flow | -3.45M | -5.51M | -4.38M |
| Debt Repayment | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a |
| Other Financial Acitivies | 468.81M | 174.10M | 161.05M |
| Financial Cash Flow | 468.81M | 174.10M | 161.05M |
| Net Cash Flow | 271.11M | n/a | n/a |
| Free Cash Flow | -197.70M | -174.10M | -161.05M |